GlassScriptPhysician profile
Sebi Chung
NPI 1629105341
$8,042.40
in general payments reported to CMS, 2019-2025
15 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $220 · 2021: $1,071 · 2022: $1,291 · 2023: $2,113 · 2024: $2,006 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,705 · Travel and Lodging: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,705.12 |
| Travel and Lodging | $834.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,506.34 | 2019-2024 | Precision 1, Total30, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $1,228.74 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $837.75 | 2023-2025 | Miebo, Xiidra, Infuse |
| Coopervision INC. | $713.34 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Biofinity Contact Lens |
| Glaukos Corporation | $312.13 | 2021-2025 | Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $280.32 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $279.94 | 2023-2024 | Eylea Hd, Eylea |
| Johnson & Johnson Surgical Vision, INC. | $257.27 | 2019-2022 | |
| New World Medical,INC. | $125.34 | 2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Novartis Pharmaceuticals Corporation | $125.00 | 2022 | |
| Astellas Pharma US INC | $115.06 | 2024 | Izervay |
| Abbvie INC. | $112.25 | 2022 | |
| Abb Con-Cise Optical Group LLC | $62.75 | 2019 | |
| Rxsight INC | $54.38 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Sight Sciences, INC. | $31.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sebi Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.